PAR PHARMACEUTICAL COMPANIES, INC.

Inactive Instrument

Par Pharmaceutical Companies, Inc. Share Price

Stocks

US69888P1066

Pharmaceuticals

End-of-day quote NYSE
- ^USD	-

18/05/15

Endo : pushes further into generics with $8 billion Par Pharma buy

RE

Latest news: Par Pharmaceutical Companies, Inc.

18/05/15

Endo : pushes further into generics with $8 billion Par Pharma buy

RE

Press Releases: Par Pharmaceutical Companies, Inc.

18/01/13	Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Begins Shipment of Generic Lamictal® XR	PU
02/01/13	Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Begins Shipment of Rizatriptan Benzoate Tablets	PU
05/12/12	Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Begins Shipment of Generic Atacand HCT®	PU
30/11/12	Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Begins Shipment of Generic Symbyax®	PU
29/10/12	Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Acquires Rights To Market And Distribute Generic Seroquel Xr® In The U.S.	PU

More press releases

News in other languages: Par Pharmaceutical Companies, Inc.

18/05/15	Endo rachète Par Parma pour créer un géant des génériques
18/05/15	Altera : Wall Street débute la semaine sans tendance
18/05/15	Wall Street débute la semaine sans tendance
18/05/15	Accenture : Les valeurs à suivre sur les marchés américains
18/05/15	Endo : rachète le génériqueur Par Pharmaceuticals

Managers and Directors: Par Pharmaceutical Companies, Inc.

Manager	Title	Age	Since
Paul Campanelli CEO	Chief Executive Officer	64	31/08/2012

Director	Title	Age	Since
Paul Campanelli BRD	Director/Board Member	64	31/08/2012

Generic Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	ELI LILLY AND COMPANY	+6.63%	+5.13%	+68.86%	+145.20%	1,148B
	JOHNSON & JOHNSON	+1.53%	+2.84%	+47.48%	+89.01%	652B
	ABBVIE INC.	+1.68%	+1.96%	+29.16%	+109.31%	505B
	ROCHE HOLDING AG	+0.73%	+2.47%	+53.85%	+68.96%	384B
	MERCK & CO., INC.	+3.83%	-0.62%	+69.01%	+42.32%	348B
	NOVARTIS AG	+2.38%	+4.27%	+33.81%	+57.95%	294B
	ASTRAZENECA PLC	+2.26%	+3.47%	+5.21%	+28.92%	264B
	AMGEN INC.	+1.97%	+3.01%	+57.91%	+76.14%	244B
	GILEAD SCIENCES, INC.	+4.03%	+5.36%	+39.76%	+116.14%	197B
	Average	+2.34%	+1.39%	+45.00%	+81.55%	448.57B
	Weighted average by Cap.	+2.25%	+1.50%	+50.23%	+95.97%

See all sector performances

Company Profile

Employees

-

Sector

Pharmaceuticals

More about the company

The best tools reserved for subscribers to boost the performance of your investments!